Cell Reprogramming & Therapeutics LLC

Milwaukee, WI

UEI
GBMRFWFDMSM8
CAGE
6XBG2
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
10437 W Innovation Dr #321, Milwaukee, WI 53226, USA
Website
cellrtherapeutics.com
Founded
2013
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel cell culture supplement from adipocyte-origin megakaryocytes and platelets - growth supplements in cell culture… R43GM165021 National Institute of General Medical Sciences (NIH) $422,285
Development of a novel, safe, easily standardized, and cost-effective cell growth supplement for diverse cell culture… R43GM161870 National Institute of General Medical Sciences (NIH) $422,285
Hypoxic chamber system for cost-effective and efficient screening of the effect of different oxygen levels on… R43TR003946 National Center for Advancing Translational Sciences (NIH) $675,000
Sbir phase i: generation of dopaminergic neurons from FAT 1819574 Division of Industrial Innovation $294,999
Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas R43CA228726 National Cancer Institute (NIH) $300,000

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Cell Reprogramming & Therapeutics LLC registered in SAM.gov?

Yes. Cell Reprogramming & Therapeutics LLC's SAM.gov registration is active through August 20, 2027.

What is Cell Reprogramming & Therapeutics LLC's most recent federal award?

Cell Reprogramming & Therapeutics LLC's most recent federal grant award is Novel cell culture supplement from adipocyte-origin megakaryocytes and platelets - growth supplements in cell culture… (R43GM165021), from National Institute of General Medical Sciences (NIH), on September 1, 2026.

On GovTribe

See Cell Reprogramming & Therapeutics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login